Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 337-340, February 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thamavit, W.
Right arrow Articles by Bhamarapravati, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thamavit, W.
Right arrow Articles by Bhamarapravati, N.

The Inhibitory Effects of {alpha}-Benzene Hexachloride on 3'-Methyl-4-dimethylaminoazobenzene and DL-Ethionine Carcinogenesis in Rats1

Witaya Thamavit, Yoshio Hiasa, Nobuyuki Ito and Natth Bhamarapravati

Department of Pathobiology, Faculty of Science, Rama VI Road, Bangkok 4, [W. T., N. B.], Thailand and Department of Pathology [Y. H.] and Cancer Institute [N. I.], Nara Medical University, Nara 634, Japan

This study was on the inhibitory effects of 0.06% {alpha}-benzene hexachloride ({alpha}-BHC) on hepatic changes including development of hepatoma in rats induced by 0.06% 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) or 0.25% DL-ethionine.

{alpha}-BHC inhibited the induction of hepatocellular carcinoma in rats treated with 3'-Me-DAB for 5 months or with ethionine for 4.5 months.

{alpha}-BHC inhibited the induction of nodular hyperplasia in rats treated with 3'-Me-DAB for 2 months or with DL-ethionine for 4.5 months but did not inhibit the induction of nodular hyperplasia in rats treated with 3'-Me-DAB for 5 months.

In addition, {alpha}-BHC inhibited the occurrence of oval cell infiltration and caused the increase in liver weight in proportion to body weight in rats treated with 3'-Me-DAB or DL-ethionine for 2 months.

1 This investigation was supported by the Faculty of Graduate Studies of Mahidol University, Bangkok, Thailand. A part of this work was submitted by Dr. Thamavit in partial fulfillment for the requirement for a Master of Science degree in Experimental Pathology at Mahidol University.

Received 7/12/73. Accepted 11/13/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.